From Public Repositories to Target Hypotheses – An End-to-End Data-to-Insights Journey for scRNA and Spatial Omics with Knowledge Graphs

Format:

From Public Repositories to Target Hypotheses An End-to-End Data-to-Insights Journey for scRNA and Spatial Omics with Knowledge Graphs

About the poster

Single-cell and spatial datasets hold immense potential but are hindered by curation bottlenecks and incompatible annotations. We present a scalable “Data-to-Insights Journey” that converts these sources into actionable target hypotheses through three core pillars.

1) LLM-augmented ETL, combined with atlas generation workflow, reduces processing time from days to minutes, retaining 90% accuracy. It addresses data fragmentation by unifying metadata and establishing common standards.

2) A scientist-ready browser for immediate access to AI-ready data products, for biologists to visually explore and validate datasets without coding.

3) Multiomics target ranking algorithm drives discovery by integrating single-cell data with other modalities. It synthesizes this multimodal landscape into prioritized targets. Furthermore refines the ranking with knowledge-based second line of evidence.

This end-to-end workflow accelerates the transition from raw data to reproducible insights, and has resulted in a discovery of a novel target that was later validated.

Poster was presented at Festival of Genomics and Biodata, London, 2026

You might be also interested in:

AI-powered bioinformatics platform visualizing biological data and model insights in a laboratory setting
The invisible bridge: How UX design can support AI success in bioinformatics?
Biotech AI data privacy in AI-driven biological and pharmaceutical research
Data Privacy Day 2026: Why Data Privacy Is Becoming a Technical Constraint in Biotech AI
Good AI practice is no longer optional in Drug Discovery – EMA and FDA set the direction
AI in biotech evolving from experimental models to regulated, production-ready drug discovery systems
AI in Biotech: Lessons from 2025 and the Trends Shaping Drug Discovery in 2026

Contact

Ready to transform drug discovery?

Discover how one of the top AI CROs in the world, can be your trusted partner in revolutionizing drug discovery through AI.

Contact us today to learn more about our tailored solutions for empowering your drug development journey.

Send us a message and we will contact you back within 48 hours.

Newsletter

Become an insider

Be the first to know about Ardigen’s latest news and get access to our publications, webinars and more!